Difficulty: Medium
Average Score: 63%
Practice
Which one of the following statements about bromocriptine is accurate?
Correct answer
C
Rationale
The correct answer is C) The drug is contraindicated in patients with a history of psychosis. This is accurate because bromocriptine, a dopamine agonist, can exacerbate or trigger psychotic symptoms in susceptible individuals. Patients with a history of psychosis are at increased risk of developing these adverse effects when treated with bromocriptine due to its action on dopamine receptors in the brain.
Option A) It should not be administered to patients taking antimuscarinic drugs is incorrect because there is no direct pharmacological interaction between bromocriptine and antimuscarinic drugs. They can be safely used together in appropriate clinical situations.
Option B) Effectiveness in Parkinson's disease requires its metabolic conversion to an active metabolite is incorrect. Bromocriptine is effective in Parkinson's disease in its parent form and does not require metabolic conversion to be active.
Option D) The drug should not be administered to patients already taking levodopa is incorrect. Bromocriptine can be used in combination with levodopa to manage symptoms of Parkinson's disease and is often part of a treatment regimen for advanced stages of the disease.
Understanding the contraindications and potential adverse effects of drugs like bromocriptine is crucial in pharmacology to ensure safe and effective treatment for patients, especially in conditions like Parkinson's disease where CNS drugs play a significant role in management.
Option A) It should not be administered to patients taking antimuscarinic drugs is incorrect because there is no direct pharmacological interaction between bromocriptine and antimuscarinic drugs. They can be safely used together in appropriate clinical situations.
Option B) Effectiveness in Parkinson's disease requires its metabolic conversion to an active metabolite is incorrect. Bromocriptine is effective in Parkinson's disease in its parent form and does not require metabolic conversion to be active.
Option D) The drug should not be administered to patients already taking levodopa is incorrect. Bromocriptine can be used in combination with levodopa to manage symptoms of Parkinson's disease and is often part of a treatment regimen for advanced stages of the disease.
Understanding the contraindications and potential adverse effects of drugs like bromocriptine is crucial in pharmacology to ensure safe and effective treatment for patients, especially in conditions like Parkinson's disease where CNS drugs play a significant role in management.